摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-(S)-2-(2-diphenylphosphino-phenyl)-4-methyl-4,5-dihydro-oxazole | 148461-12-5

中文名称
——
中文别名
——
英文名称
(-)-(S)-2-(2-diphenylphosphino-phenyl)-4-methyl-4,5-dihydro-oxazole
英文别名
(S)-2-[2'-(diphenylphosphanyl)phenyl]-4-methyl-4,5-dihydrooxazole;(4S)-2-(2-diphenylphosphinophenyl)-4-methyl-1,3-oxazoline;(4S)-2-(2-diphenylphosphino)phenyl)-4-methyl-1,3-oxazoline;PN(Me);[2-[(4S)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]-diphenylphosphane
(-)-(S)-2-(2-diphenylphosphino-phenyl)-4-methyl-4,5-dihydro-oxazole化学式
CAS
148461-12-5
化学式
C22H20NOP
mdl
——
分子量
345.381
InChiKey
LPALMDOOEDKULS-KRWDZBQOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    85-90 °C
  • 沸点:
    474.2±28.0 °C(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    21.6
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 危险类别码:
    R36/37/38
  • 安全说明:
    S26,S37/39

SDS

SDS:d3429f3f9ceae6f35fa56cdb4ccc18c3
查看

反应信息

  • 作为反应物:
    描述:
    氟硼酸钠 、 bis[dichloro(pentamethylcyclopentadienyl)iridium(III)] 、 (-)-(S)-2-(2-diphenylphosphino-phenyl)-4-methyl-4,5-dihydro-oxazole甲醇 为溶剂, 以74%的产率得到[(η5-C5Ne5)IrCl((4S)-2-(2-diphenylphosphino)phenyl)-4-methyl-1,3-oxazoline)](BF4)
    参考文献:
    名称:
    金属手性膦恶唑啉-铑(III)和-铱(III)配合物的合成,表征,性质和不对称催化Diels-Alder反应§
    摘要:
    光学活性phosphinooxazoline复合体(的合成和表征[R的Rh和小号的Rh) - [(η 5 -C 5我5)的RhCl(PN)] [A](PN =(4小号)-2-(2-二苯基膦基)苯基)-4-异丙基-1,3-恶唑啉(PN(i Pr)),A = SbF 6(1a,1a '),A = BF 4(1b,1b '); PN =(4 S)-2-(2-二苯基膦基)苯基)-4-甲基-1,3-恶唑啉(PN(Me)),A = SbF 6(2a,2a '),A = BF 4(2b,2b '); PN =(3a S,8a R)-2-(2-二苯基膦基)苯基)-3a,8a-二氢茚满[1,2-d]恶唑](PN(Ind)),A = SbF 6(3a,3a ' )),(小号的Rh和- [R的Rh) - [(η 5 -C 5我5)RHI(PN(Me)中)] [的SbF 6 ](图4a,图4a “)和(- [R的Ir和小号的Ir)
    DOI:
    10.1021/om020582o
  • 作为产物:
    参考文献:
    名称:
    含2-芳基恶唑啉的手性磷,硫和硒的制备
    摘要:
    由市售或合成的氨基醇制备一系列对映体纯的2- [2-(二芳基膦基)芳基]-恶唑啉。对于恶唑啉的形成,采用了三种程序:(i)与2-卤代苯甲酸一锅缩合,(ii)ZnCl 2与2-卤代苯甲腈-苯胺催化缩合,和(iii)通过2-卤代苯甲酰胺的三步顺序和甲苯磺酸盐或氯化物。通过非对映选择性亲核取代Ar 1 Ar 2 PC1的卤化物或通过LiPAr 1 Ar 2亲核芳族取代制备含有立体异构磷的膦恶唑啉。另外,制备了硫和硒类似物。
    DOI:
    10.1016/0040-4020(96)00267-0
点击查看最新优质反应信息

文献信息

  • [EN] ISOCARBOSTYRIL ALKALOIDS AND FUNCTIONALIZATION THEREOF<br/>[FR] ALCALOÏDES D'ISOCARBOSTYRILE ET LEUR FONCTIONNALISATION
    申请人:UNIV ILLINOIS
    公开号:WO2020117894A1
    公开(公告)日:2020-06-11
    Enantioselective total syntheses of the anticancer isocarbostyril alkaloids (+)-7-deoxypancratistatin, (+)-pancratistatin, (+)-lycoricidine, and (+)-narciclasine are described. Our strategy for accessing this unique class of natural products is based on the development of a Ni-catalyzed dearomative trans-1,2-carboamination of benzene. The effectiveness of this dearomatization approach is notable, as only two additional olefin functionalizations are needed to construct the fully decorated aminocyclitol cores of these alkaloids. Installation of the lactam ring has been achieved through several pathways and a direct interconversion between natural products was established via a late-stage C-7 cupration. Using this synthetic blueprint, we were able to produce natural products on a gram scale and provide tailored analogs with improved activity, solubility, and metabolic stability.
    对抗癌异喹啉生物碱(+)-7-去氧胰蛋白酶素、(+)-胰蛋白酶素、(+)-莱科里西丁和(+)-纳西克拉辛的对映选择性全合成被描述。我们用于获取这一独特类天然产物的策略基于苯的Ni催化去芳构建trans-1,2-碳胺化反应。这种去芳构建方法的有效性显著,因为只需要另外两个烯烃官能团化合物即可构建这些生物碱的完全修饰的基环糖核。通过几种途径实现了内酰胺环的安装,并通过晚期C-7杯化反应建立了天然产物之间的直接互变。利用这一合成蓝图,我们能够以克为单位生产天然产物,并提供具有改进活性、溶解性和代谢稳定性的定制类似物。
  • Chiral Phosphinooxazoline−Ruthenium(II) and −Osmium(II) Complexes as Catalysts in Diels−Alder Reactions
    作者:Daniel Carmona、Cristina Vega、Néstor García、Fernando J. Lahoz、Sergio Elipe、Luis A. Oro、M. Pilar Lamata、Fernando Viguri、Rosana Borao
    DOI:10.1021/om050973d
    日期:2006.3.1
    SRu)-[(η6-p-MeC6H4iPr)Ru(OPOF2)(PNiPr)][PF6] have been determined by X-ray diffractometric methods. Dichloromethane solutions of the aqua complexes [(η6-p-MeC6H4iPr)M(PN)(H2O)][SbF6]2 are active catalysts for the Diels−Alder reaction between methacrolein and cyclopentadiene. The reaction occurs rapidly at room temperature with good exo:endo selectivity (from 85:15 to 96:4) and moderate enantioselectivity (up to
    光学活性phosphinooxazoline化物复合物(的合成和表征小号中号和- [R中号) - [(η 6 - p -MeC 6 ħ 4我PR)的MC1(PN)] A(M =; PN = phosphinooxazoline配体; A =抗衡阴离子)和导出的性络合物([R中号和小号中号) - [(η 6 - p -MeC 6 ħ 4我PR)M(PN)(H 2 O)](A)2报告。含OPOF 2的化合物(R M和S中号) - [(η 6 - p -MeC 6 ħ 4我PR)M(OPOF 2)(PN我PR)] [PF 6 ](M =; PN我PR =(4小号)-2-还已经制备并表征了(2-二苯基膦基苯基)-4-异丙基-1,3-恶唑啉。的分子结构(小号中号) - [(η 6 - p -MeC 6 ħ 4我PR)的MC1(PN我PR)] [的SbF 6 ](M =),(小号的Ru)
  • GEM-DISUBSTITUTED PYRROLIDINES, PIPERAZINES, AND DIAZEPANES, AND COMPOSITIONS AND METHODS OF MAKING THE SAME
    申请人:California Institute of Technology
    公开号:US20200199114A1
    公开(公告)日:2020-06-25
    Described here are transition metal-catalyzed enantioselective arylation and vinylation reactions of α-substituted lactams, such as γ-lactams. The use of various electrophiles and ligands are described, and result in the construction of α-quaternary centers in good yields (up to 91% yield) and high enantioselectivities (up to 97% ee).
    本文描述了过渡属催化的α-取代内酰胺(如γ-内酰胺)的选择性芳基化和烯基化反应。描述了使用各种亲电试剂和配体,并导致在良好产率(高达91%收率)和高对映选择性(高达97% ee)下构建α-季中心。
  • Preparation of novel Sulfur and phosphorus containing oxazolines as ligands for asymmetric catalysis
    作者:Joanne V. Allen、Graham J. Dawson、Christopher G. Frost、Ionathan M.J. Williams、Steven J. Coote
    DOI:10.1016/s0040-4020(01)80795-x
    日期:1994.1
    The preparation of enantiomerically pure liginds which contain both an oxazoline group and an additional sulfur or phosphorus donor atom are described. Methyithiomethyl, o-thioanisyl and thienyl oxazolines have been prepared in one step, and o-diphenylphosphinophenyl oxazolines have been prepared in two steps in good yields from commercially available starting materials.
    描述了同时包含恶唑啉基团和另外的供体原子的对映体纯的配体的制备。一步法制得了甲基甲基,邻代茴香基和噻吩恶唑啉,并分两步从可商购的起始原料中以高收率制备了邻二苯基膦基苯基恶唑啉。
  • Metal catalyzed dearomative 1,2-carboamination
    申请人:The Board of Trustees of the University of Illinois
    公开号:US10336737B2
    公开(公告)日:2019-07-02
    Described herein is the development of an arenophile-mediated, nickel-catalyzed dearomative trans-1,2-carboamination protocol. A range of readily available aromatic compounds was converted to the corresponding dienes using Grignard reagents as nucleophiles. This strategy provided products with exclusive trans-selectivity and high enantioselectivity was observed in case of benzene and naphthalene. The utility of this methodology was showcased by controlled and stereoselective preparation of small, functionalized molecules. A concise synthesis of (+)-pancratistatin and (+)-7-deoxypancratistatin from benzene using an enantioselective, dearomative carboamination strategy has been achieved. This approach, in combination with the judicious choice of subsequent olefin-type difunctionalization reactions, permits rapid and controlled access to a hexasubstituted core. Finally, minimal use of intermediary steps as well as direct, late stage C-7 hydroxylation provides both natural products in six and seven operations.
    本文介绍了一种由亲腈剂介导、催化的脱芳香反式-1,2-羧化反应。以格氏试剂为亲核剂,一系列现成的芳香族化合物被转化为相应的二烯。这种方法提供的产品具有独特的反式选择性,苯和的对映选择性也很高。通过控制和立体选择性制备功能化小分子,展示了这一方法的实用性。 利用对映选择性脱芳羧化策略,以苯为原料简便地合成了 (+)-pancratistatin 和 (+)-7-deoxypancratistatin 。这种方法与后续烯烃类双官能化反应的明智选择相结合,可以快速、可控地获得六代核心。最后,使用最少的中间步骤以及直接的后期 C-7 羟基化反应,只需六次和七次操作就能得到两种天然产品。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫